Physicochemical property and skin damage of physical mixture of valsartan and polysorbate 80 |
Choi, Han-Gon
(College of Pharmacy, Yeungnam University)
Sung, Jun-Ho (College of Pharmacy, Yeungnam University) Oh, Dong-Hoon (College of Pharmacy, Yeungnam University) Li, Dong-Xun (College of Pharmacy, Yeungnam University) Cho, Kwan-Hyung (College of Pharmacy, Yeungnam University) Woo, Jong-Soo (College of Pharmacy, Yeungnam University) Yong, Chul-Soon (College of Pharmacy, Yeungnam University) |
1 | S. Oparil, S. Dyke, F. Harris, J. Kief, D. James, A. Hester and S. Fitzsimmons, The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension, Clin Ther., 18 (5), (1996). DOI ScienceOn |
2 | F. Waldmeier, G. Flesch, P. MuLler, T. Winkler, H.P. Kriemler, P. Buhlmayer and M.D. Gasparo, Pharmacokinetics, disposition and biotransformation of [14C]- radiolabelled valsartan in healthy male volunteers after a single oral dose, Xenobiotica, 27 (1), 59–71 (1997). |
3 | M.D. Gasparo and S. Whitebread, Binding of valsartan to mammalian angiotensin AT1 receptors, Regul. Pept., 59, 303-311 (1995). DOI ScienceOn |
4 | Y. Mizuta, H. Kai, M. Fukui and T. Imaizumi, Long-term treatment with valsartan attenuates myocardial fibrosis and improves diastolic dysfunction in hypertensive patients The echorcardiographic assessment, J. of Cardiac Failure, 14 (7), S150 (2008). DOI ScienceOn |
5 | L.M. Prisant, K.L. Thomas, E.F. Lewis, Z. Huang, G.S. Francis, W. D. Weaver, M.A. Pfeffer, J.J.V. McMurray, R.M. Califf and E.J. Velazquez, Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both, J. Am. Coll. Cardiol., 51 (19), 1865-1871 (2008). DOI ScienceOn |
6 | C.J. Mbah, Solubilization of valsartan by aqueous glycerol, polyethylene glycol and micellar solutions, Pharmazie., 61 (4), 322-324 (2006). |
7 | B. Cappello, C.D. Maio, M. Iervilino and A. Miro, Improvement of solubility and stability of valsartan by hydroxypropyl--cyclodextrin, J. Inclusion Phenom. Macrocyclic Chem., 54, 289-294 (2006). DOI |
8 | P.D Martino, R. Censi, C. Barthélémy, R. Gobetto, E. Joiris, A. Masic, P. Odou and S. Martelli, Characterization and compaction behaviour of nimesulide crystal forms, Int. J. Pharm., 342 (1), 137-144 (2007). DOI ScienceOn |
9 | M. Schierholz, Physico-chemical properties of a rifampicinreleasing polydimethylsiloxane shunt, Biomaterials. 18 (8), 635-641 (1997). DOI ScienceOn |
10 | L. Benassi, G. Bertazzoni, C. Magnoni, M. Rinaldi, C. Fontanesi and S. Seidenari, Decrease in toxic potential of mixed tensides maintained below the critical micelle concentration: an in vitro study, Skin Pharmacol Appl Skin Physiol., 16 (3), 156-164 (2003). DOI ScienceOn |
11 | S. Zalac, M.Z. Khan, V. Gabelica, M. Tudja, E. Mestrovic and M. Romih, Paracetamol-propyphenazone interaction and formulation difficulties associated with eutectic formation in combination solid dosage forms, Chem. Pharm. Bull,, 47 (3), 302-307 (1999). DOI ScienceOn |
12 | G.L. Amidon, H. Lennernäs, V.P. Shah and J.R. Crison, A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res., 12, 413-420 (1995). DOI ScienceOn |
13 | W. Wasylaschuk, P. Harmon, G. Wagner, A. Harman, A. Templeton, H. Xu and R. Reed, Evaluation of hydroperoxides in common pharmaceutical excipients, J. Pharm. Sci., 96 (1), 106-116 (2007). DOI ScienceOn |
14 | A.N. Hassan and J.F. Frank, Influence of surfactant hydrophobicity on the detachment of Escherichia coli O157:H7 from lettuce, Int. J. Food Microbiol., 87 (1-2), 145-152 (2003). DOI ScienceOn |
15 | C.F. Rawlinson, A.C. Williams, P. Timmins and I. Grimsey, Polymer-mediated disruption of drug crystallinity, Int. J. Pharm., 336 (1), 42-48 (2007). DOI ScienceOn |
16 | B.C. Hancock and G. Zografi, Characteristics and significance of the amorphous state in pharmaceutical systems, J. Pharm. Sci., 86 (1), 1–12 (1997). DOI ScienceOn |
17 | J.L. Pool, R. Glazer, M. Weinberger, R. Alvarado, J. Huang and A. Graff, Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: A double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults, Clin Ther., 29 (1), 61-73 (2007). DOI ScienceOn |
18 | S. Sheetal, K.B. Anil, K.S. Rakesh, B. Tanim, M. Amarnath and M. Amarnath, Pharmacoscintigraphic Evaluation of Polysorbate 80-Coated Chitosan Nanoparticles for Brain Targeting, American J. of Drug Delivery, 3(3), 205-212 (2005). DOI ScienceOn |
19 | L.A. Felton, T. Austin-Forbes and T.A. Moore, Influence of surfactants in aqueous-based polymeric dispersions on the thermomechanical and adhesive properties of acrylic films, Drug Dev. Ind. Pharm., 26 (2), 205-210 (2000). DOI ScienceOn |